Skip to main content

Table 2 Demographic summary

From: EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex

Demographic characteristics Everolimus
N  =  120
Age, median (range), years 11.0 (1–47) a
Sex, n (%)
 Male 62 (51.7)
 Female 58 (48.3)
Race, n (%)
 Caucasian 116 (96.7)
 Asian 2 (1.7)
 Native American 1 (0.8)
 Other 1 (0.8)
  1. aone patient was 1 year old (protocol deviation)